A quantitative rabbit model of vaccinia keratitis

Sharon Altmann, Andrew Emanue, Megan Toomey, Kim McIntyre, Jill Covert, Richard Redd Dubielzig, Gary Leatherberry, Christopher J Murphy, Shantha Kodihalli, Curtis R. Brandt

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

PURPOSE. The goal of this study was to use multiple quantitative disease measures to evaluate the effect of various viral inocula on the development of vaccinia keratitis in rabbits. METHODS. Trephined eyes of female rabbits were infected with 104, 105, 106, or 107 plaque-forming units (pfu) of the Dryvax strain of the vaccinia virus and scored daily for disease for 14 days according to a modification of the MacDonald-Shadduck scoring system. Ocular viral titers and vaccinia-specific antibody titers were determined by plaque assay and ELISA, respectively. RESULTS. The amount of virus used for infection affected the severity of disease, with 104 pfu eliciting milder keratitis afterdelayed onset compared with higher amounts of virus. At inocula above 105 pfu the course and severity of corneal disease was not significantly different. The time to reach peak titers was delayed in the 104 group but peak titers were similar in all groups. Severe conjunctival chemosis interfered with scoring in animals infected with 106 or 107 pfu. Virus-specificantibody titers were similar in all groups at day 14. Body weights decreased less than 10% in all groups. CONCLUSIONS. The course of vaccinia keratitis in rabbits paralleled that in humans. A viral inoculum of 105 pfu/eye was determined to be optimal for use in further studies of vaccinia keratitis.

Original languageEnglish (US)
Pages (from-to)4531-4540
Number of pages10
JournalInvestigative Ophthalmology and Visual Science
Volume51
Issue number9
DOIs
StatePublished - Sep 2010

Fingerprint

Vaccinia
Keratitis
Rabbits
Smallpox Vaccine
Corneal Diseases
Vaccinia virus
Virus Diseases
Viral Load
Enzyme-Linked Immunosorbent Assay
Body Weight
Viruses
Antibodies

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience
  • Medicine(all)

Cite this

Altmann, S., Emanue, A., Toomey, M., McIntyre, K., Covert, J., Dubielzig, R. R., ... Brandt, C. R. (2010). A quantitative rabbit model of vaccinia keratitis. Investigative Ophthalmology and Visual Science, 51(9), 4531-4540. https://doi.org/10.1167/iovs.09-5106

A quantitative rabbit model of vaccinia keratitis. / Altmann, Sharon; Emanue, Andrew; Toomey, Megan; McIntyre, Kim; Covert, Jill; Dubielzig, Richard Redd; Leatherberry, Gary; Murphy, Christopher J; Kodihalli, Shantha; Brandt, Curtis R.

In: Investigative Ophthalmology and Visual Science, Vol. 51, No. 9, 09.2010, p. 4531-4540.

Research output: Contribution to journalArticle

Altmann, S, Emanue, A, Toomey, M, McIntyre, K, Covert, J, Dubielzig, RR, Leatherberry, G, Murphy, CJ, Kodihalli, S & Brandt, CR 2010, 'A quantitative rabbit model of vaccinia keratitis', Investigative Ophthalmology and Visual Science, vol. 51, no. 9, pp. 4531-4540. https://doi.org/10.1167/iovs.09-5106
Altmann S, Emanue A, Toomey M, McIntyre K, Covert J, Dubielzig RR et al. A quantitative rabbit model of vaccinia keratitis. Investigative Ophthalmology and Visual Science. 2010 Sep;51(9):4531-4540. https://doi.org/10.1167/iovs.09-5106
Altmann, Sharon ; Emanue, Andrew ; Toomey, Megan ; McIntyre, Kim ; Covert, Jill ; Dubielzig, Richard Redd ; Leatherberry, Gary ; Murphy, Christopher J ; Kodihalli, Shantha ; Brandt, Curtis R. / A quantitative rabbit model of vaccinia keratitis. In: Investigative Ophthalmology and Visual Science. 2010 ; Vol. 51, No. 9. pp. 4531-4540.
@article{39dbf1ff3d1641bfacd8e2f8db878d99,
title = "A quantitative rabbit model of vaccinia keratitis",
abstract = "PURPOSE. The goal of this study was to use multiple quantitative disease measures to evaluate the effect of various viral inocula on the development of vaccinia keratitis in rabbits. METHODS. Trephined eyes of female rabbits were infected with 104, 105, 106, or 107 plaque-forming units (pfu) of the Dryvax strain of the vaccinia virus and scored daily for disease for 14 days according to a modification of the MacDonald-Shadduck scoring system. Ocular viral titers and vaccinia-specific antibody titers were determined by plaque assay and ELISA, respectively. RESULTS. The amount of virus used for infection affected the severity of disease, with 104 pfu eliciting milder keratitis afterdelayed onset compared with higher amounts of virus. At inocula above 105 pfu the course and severity of corneal disease was not significantly different. The time to reach peak titers was delayed in the 104 group but peak titers were similar in all groups. Severe conjunctival chemosis interfered with scoring in animals infected with 106 or 107 pfu. Virus-specificantibody titers were similar in all groups at day 14. Body weights decreased less than 10{\%} in all groups. CONCLUSIONS. The course of vaccinia keratitis in rabbits paralleled that in humans. A viral inoculum of 105 pfu/eye was determined to be optimal for use in further studies of vaccinia keratitis.",
author = "Sharon Altmann and Andrew Emanue and Megan Toomey and Kim McIntyre and Jill Covert and Dubielzig, {Richard Redd} and Gary Leatherberry and Murphy, {Christopher J} and Shantha Kodihalli and Brandt, {Curtis R.}",
year = "2010",
month = "9",
doi = "10.1167/iovs.09-5106",
language = "English (US)",
volume = "51",
pages = "4531--4540",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "9",

}

TY - JOUR

T1 - A quantitative rabbit model of vaccinia keratitis

AU - Altmann, Sharon

AU - Emanue, Andrew

AU - Toomey, Megan

AU - McIntyre, Kim

AU - Covert, Jill

AU - Dubielzig, Richard Redd

AU - Leatherberry, Gary

AU - Murphy, Christopher J

AU - Kodihalli, Shantha

AU - Brandt, Curtis R.

PY - 2010/9

Y1 - 2010/9

N2 - PURPOSE. The goal of this study was to use multiple quantitative disease measures to evaluate the effect of various viral inocula on the development of vaccinia keratitis in rabbits. METHODS. Trephined eyes of female rabbits were infected with 104, 105, 106, or 107 plaque-forming units (pfu) of the Dryvax strain of the vaccinia virus and scored daily for disease for 14 days according to a modification of the MacDonald-Shadduck scoring system. Ocular viral titers and vaccinia-specific antibody titers were determined by plaque assay and ELISA, respectively. RESULTS. The amount of virus used for infection affected the severity of disease, with 104 pfu eliciting milder keratitis afterdelayed onset compared with higher amounts of virus. At inocula above 105 pfu the course and severity of corneal disease was not significantly different. The time to reach peak titers was delayed in the 104 group but peak titers were similar in all groups. Severe conjunctival chemosis interfered with scoring in animals infected with 106 or 107 pfu. Virus-specificantibody titers were similar in all groups at day 14. Body weights decreased less than 10% in all groups. CONCLUSIONS. The course of vaccinia keratitis in rabbits paralleled that in humans. A viral inoculum of 105 pfu/eye was determined to be optimal for use in further studies of vaccinia keratitis.

AB - PURPOSE. The goal of this study was to use multiple quantitative disease measures to evaluate the effect of various viral inocula on the development of vaccinia keratitis in rabbits. METHODS. Trephined eyes of female rabbits were infected with 104, 105, 106, or 107 plaque-forming units (pfu) of the Dryvax strain of the vaccinia virus and scored daily for disease for 14 days according to a modification of the MacDonald-Shadduck scoring system. Ocular viral titers and vaccinia-specific antibody titers were determined by plaque assay and ELISA, respectively. RESULTS. The amount of virus used for infection affected the severity of disease, with 104 pfu eliciting milder keratitis afterdelayed onset compared with higher amounts of virus. At inocula above 105 pfu the course and severity of corneal disease was not significantly different. The time to reach peak titers was delayed in the 104 group but peak titers were similar in all groups. Severe conjunctival chemosis interfered with scoring in animals infected with 106 or 107 pfu. Virus-specificantibody titers were similar in all groups at day 14. Body weights decreased less than 10% in all groups. CONCLUSIONS. The course of vaccinia keratitis in rabbits paralleled that in humans. A viral inoculum of 105 pfu/eye was determined to be optimal for use in further studies of vaccinia keratitis.

UR - http://www.scopus.com/inward/record.url?scp=77957331966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957331966&partnerID=8YFLogxK

U2 - 10.1167/iovs.09-5106

DO - 10.1167/iovs.09-5106

M3 - Article

C2 - 20375331

AN - SCOPUS:77957331966

VL - 51

SP - 4531

EP - 4540

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 9

ER -